当前位置: 首页 >> 检索结果
共有 16360 条符合本次的查询结果, 用时 5.2537959 秒

881. Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4.

作者: Liang Li.;Jing Tang.;Baohua Zhang.;Wen Yang.;Miyang LiuGao.;Ruoyu Wang.;Yexiong Tan.;Jianling Fan.;Yanxin Chang.;Jing Fu.;Feng Jiang.;Caiyang Chen.;Yingcheng Yang.;Jin Gu.;Dingming Wu.;Linna Guo.;Dan Cao.;Hengyu Li.;Guangwen Cao.;Mengchao Wu.;Michael Q Zhang.;Lei Chen.;Hongyang Wang.
来源: Gut. 2015年64卷1期156-67页
Liver tumour-initiating cells (T-ICs) are critical for hepatocarcinogenesis. However, the underlying mechanism regulating the function of liver T-ICs remains unclear.

882. Authors' response: The role of risedronate in osteopenia in Crohn's disease.

作者: Ad A van Bodegraven.;Birgit I Witte.;Paul Lips.; .
来源: Gut. 2015年64卷1期185-6页

883. IBS with intestinal microbial dysbiosis: a new and clinically relevant subgroup?

作者: Magnus Simrén.
来源: Gut. 2014年63卷11期1685-6页

884. CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis.

作者: Josef Ehling.;Matthias Bartneck.;Xiao Wei.;Felix Gremse.;Viktor Fech.;Diana Möckel.;Christer Baeck.;Kanishka Hittatiya.;Dirk Eulberg.;Tom Luedde.;Fabian Kiessling.;Christian Trautwein.;Twan Lammers.;Frank Tacke.
来源: Gut. 2014年63卷12期1960-1971页
In chronic liver injury, angiogenesis, the formation of new blood vessels from pre-existing ones, may contribute to progressive hepatic fibrosis and to development of hepatocellular carcinoma. Although hypoxia-induced expression of vascular endothelial growth factor (VEGF) occurs in advanced fibrosis, we hypothesised that inflammation may endorse hepatic angiogenesis already at early stages of fibrosis.

885. Histamine H4 and H1 receptors contribute to postinflammatory visceral hypersensitivity.

作者: Annemie Deiteren.;Joris G De Man.;Nathalie E Ruyssers.;Tom G Moreels.;Paul A Pelckmans.;Benedicte Y De Winter.
来源: Gut. 2014年63卷12期1873-82页
Substantial evidence implicates mast cells and their main constituent histamine in the pathogenesis of visceral hypersensitivity. We explored the specific contribution of histamine H4 (H4R) and H1 (H1R) receptors to visceral hypersensitivity in a postinflammatory rat model.

886. Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity.

作者: Ingunn M Stromnes.;J Scott Brockenbrough.;Kamel Izeradjene.;Markus A Carlson.;Carlos Cuevas.;Randi M Simmons.;Philip D Greenberg.;Sunil R Hingorani.
来源: Gut. 2014年63卷11期1769-81页
Pancreatic ductal adenocarcinoma (PDA) is characterised by a robust desmoplasia, including the notable accumulation of immunosuppressive cells that shield neoplastic cells from immune detection. Immune evasion may be further enhanced if the malignant cells fail to express high levels of antigens that are sufficiently immunogenic to engender an effector T cell response.

887. Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN.

作者: H Fontaine.;S Kahi.;C Chazallon.;M Bourgine.;A Varaut.;C Buffet.;O Godon.;J F Meritet.;Y Saïdi.;M L Michel.;D Scott-Algara.;J P Aboulker.;S Pol.; .
来源: Gut. 2015年64卷1期139-47页
The antiviral efficacy of nucleos(t)ide analogues whose main limitation is relapse after discontinuation requires long-term therapy. To overcome the risk of relapse and virological breakthrough during long-term therapy, we performed a phase I/II, open, prospective, multicentre trial using a HBV envelope-expressing DNA vaccine.

888. Type I interferon signalling in the intestinal epithelium affects Paneth cells, microbial ecology and epithelial regeneration.

作者: Markus Tschurtschenthaler.;Jun Wang.;Cornelia Fricke.;Teresa M J Fritz.;Lukas Niederreiter.;Timon E Adolph.;Edina Sarcevic.;Sven Künzel.;Felix A Offner.;Ulrich Kalinke.;John F Baines.;Herbert Tilg.;Arthur Kaser.
来源: Gut. 2014年63卷12期1921-31页
Intestinal epithelial cells (IECs) at the internal/external interface orchestrate the mucosal immune response. Paneth cells secrete antimicrobial peptides and inflammatory mediators, protect from pathogens and shape the commensal microbiota. Prompted by the genetic association of the locus harbouring the type I interferon (IFN) receptor (IFNAR1) with Crohn's disease, and a transcriptional signature for type I IFN signalling in Paneth cells, we studied the function of IFNAR1 in IECs.

889. The stem cell organisation, and the proliferative and gene expression profile of Barrett's epithelium, replicates pyloric-type gastric glands.

作者: Danielle L Lavery.;Anna M Nicholson.;Richard Poulsom.;Rosemary Jeffery.;Alia Hussain.;Laura J Gay.;Janusz A Jankowski.;Sebastian S Zeki.;Hugh Barr.;Rebecca Harrison.;James Going.;Sritharan Kadirkamanathan.;Peter Davis.;Timothy Underwood.;Marco R Novelli.;Manuel Rodriguez-Justo.;Neil Shepherd.;Marnix Jansen.;Nicholas A Wright.;Stuart A C McDonald.
来源: Gut. 2014年63卷12期1854-63页
Barrett's oesophagus shows appearances described as 'intestinal metaplasia', in structures called 'crypts' but do not typically display crypt architecture. Here, we investigate their relationship to gastric glands.

890. Prolactin mediates psychological stress-induced dysfunction of regulatory T cells to facilitate intestinal inflammation.

作者: Wei Wu.;Mingming Sun.;Huan-Ping Zhang.;Tengfei Chen.;Ruijin Wu.;Changqin Liu.;Gui Yang.;Xiao-Rui Geng.;Bai-Sui Feng.;Zhigang Liu.;Zhanju Liu.;Ping-Chang Yang.
来源: Gut. 2014年63卷12期1883-92页
The dysfunction of immune regulation plays a critical role in the pathogenesis of a number of chronic inflammatory disorders, such as IBD. A close relationship between psychological stress and intestinal inflammation has been noted; the underlying mechanism remains elusive. This study aims to elucidate a pathological pathway between psychological stress and the dysfunction of regulatory T cells (Treg), and its effect on facilitating intestinal inflammation.

891. Involvement of interleukin-17A-induced expression of heat shock protein 47 in intestinal fibrosis in Crohn's disease.

作者: Yusuke Honzawa.;Hiroshi Nakase.;Masahiro Shiokawa.;Takuya Yoshino.;Hirotsugu Imaeda.;Minoru Matsuura.;Yuzo Kodama.;Hiroki Ikeuchi.;Akira Andoh.;Yoshiharu Sakai.;Kazuhiro Nagata.;Tsutomu Chiba.
来源: Gut. 2014年63卷12期1902-12页
Intestinal fibrosis is a clinically important issue in Crohn's disease (CD). Heat shock protein (HSP) 47 is a collagen-specific molecular chaperone involved in fibrotic diseases. The molecular mechanisms of HSP47 induction in intestinal fibrosis related to CD, however, remain unclear. Here we investigated the role of interleukin (IL)-17A-induced HSP47 expression in intestinal fibrosis in CD.

892. α-Haemolysin of Escherichia coli in IBD: a potentiator of inflammatory activity in the colon.

作者: Roland Bücker.;Emanuel Schulz.;Dorothee Günzel.;Christian Bojarski.;In-Fah M Lee.;Lena J John.;Stephanie Wiegand.;Traute Janßen.;Lothar H Wieler.;Ulrich Dobrindt.;Lothar Beutin.;Christa Ewers.;Michael Fromm.;Britta Siegmund.;Hanno Troeger.;Jörg-Dieter Schulzke.
来源: Gut. 2014年63卷12期1893-901页
α-Haemolysin (HlyA) influences host cell ionic homeostasis and causes concentration-dependent cell lysis. As a consequence, HlyA-producing Escherichia coli is capable of inducing 'focal leaks' in colon epithelia, through which bacteria and antigens translocate. This study addressed the role of HlyA as a virulence factor in the pathogenesis of colitis according to the 'leaky gut' concept.

893. Mevalonate kinase deficiency and IBD: shared genetic background.

作者: Anna Monica Bianco.;Martina Girardelli.;Diego Vozzi.;Sergio Crovella.;Giulio Kleiner.;Annalisa Marcuzzi.
来源: Gut. 2014年63卷8期1367-8页

894. Hepatocellular carcinoma: clinical frontiers and perspectives.

作者: Jordi Bruix.;Gregory J Gores.;Vincenzo Mazzaferro.
来源: Gut. 2014年63卷5期844-55页
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death and is currently the main event leading to death in patients with cirrhosis. Evolving information suggests that the metabolic syndrome with non-alcoholic liver disease may be an important cause of HCC in addition to viral hepatitis and alcohol-induced liver disease. The molecular pathogenesis is extremely complex and heterogeneous. To date the molecular information has not impacted on treatment decisions. Periodic surveillance imaging of patients with cirrhosis is widely practiced, especially because diagnostic, radiographic criteria for early-stage HCC have been defined (including nodules between 1 and 2 cm) and effective treatment is available for tumours detected at an early stage. Worldwide the approach to resection versus transplantation varies depending upon local resources, expertise and donor availability. The criteria for transplantation are discussed, and the controversial areas highlighted with evidence-based recommendations provided. Several approaches are available for intermediate stage disease, including radiofrequency ablation, transarterial chemoembolisation and radioembolisation; the rationale for these therapies is buttressed by appropriate outcome-based studies. For advanced disease, systemic therapy with sorafenib remains the option best supported by current data. Thus, while several trials have failed to improve the benefits of established therapies, studies assessing the sequential or combined application of those already known to be beneficial are needed. Also, new concepts are provided in regards to selecting and stratifying patients for second-line studies, which may help explain the failure of prior studies.

895. LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma.

作者: Jiagen Li.;Zhaoli Chen.;Liqing Tian.;Chengcheng Zhou.;Max Yifan He.;Yibo Gao.;Suya Wang.;Fang Zhou.;Susheng Shi.;Xiaoli Feng.;Nan Sun.;Ziyuan Liu.;Geir Skogerboe.;Jingsi Dong.;Ran Yao.;Yuda Zhao.;Jian Sun.;Baihua Zhang.;Yue Yu.;Xuejiao Shi.;Mei Luo.;Kang Shao.;Ning Li.;Bin Qiu.;Fengwei Tan.;Runsheng Chen.;Jie He.
来源: Gut. 2014年63卷11期1700-10页
Oesophageal cancer is one of the most deadly forms of cancer worldwide. Long non-coding RNAs (lncRNAs) are often found to have important regulatory roles.

896. IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis.

作者: Ivan J Fuss.;Bharat Joshi.;Zhiqiong Yang.;Heba Degheidy.;Stefan Fichtner-Feigl.;Heitor de Souza.;Florian Rieder.;Franco Scaldaferri.;Anja Schirbel.;Melania Scarpa.;Gail West.;Chuli Yi.;Lili Xu.;Pamela Leland.;Michael Yao.;Peter Mannon.;Raj K Puri.;Claudio Fiocchi.;Warren Strober.
来源: Gut. 2014年63卷11期1728-36页
Previous studies have shown that ulcerative colitis (UC) is associated with the presence of lamina propria non-invariant (Type II) NKT cells producing IL-13 and mediating epithelial cell cytotoxicity. Here we sought to define the antigen(s) stimulating the NKT cells and to quantitate these cells in the UC lamina propria.

897. Chemokines and alcoholic hepatitis: are chemokines good therapeutic targets?

作者: Bin Gao.;Mingjiang Xu.
来源: Gut. 2014年63卷11期1683-4页

898. Synchronous superficial spreading lesions of the stomach.

作者: Tsutomu Namikawa.;Michiya Kobayashi.;Kazuhiro Hanazaki.
来源: Gut. 2014年63卷7期1172, 1194页

899. Author's response: Hepatitis B virus seromarkers clearance and risk of hepatocellular carcinoma: serious risks of misinterpretation.

作者: Jessica Liu.;Hwai-I Yang.;Chien-Jen Chen.
来源: Gut. 2015年64卷1期186-7页

900. Osteopontin induces ductular reaction contributing to liver fibrosis.

作者: Xiaodong Wang.;Aritz Lopategi.;Xiaodong Ge.;Yongke Lu.;Naoto Kitamura.;Raquel Urtasun.;Tung-Ming Leung.;Maria Isabel Fiel.;Natalia Nieto.
来源: Gut. 2014年63卷11期1805-18页
In human chronic liver disease, there is association between ductular reaction (DR) and fibrosis; yet, the mechanism triggering its onset and its role in scar formation remains unknown. Since we previously showed that osteopontin (OPN) is highly induced during drug-induced liver fibrosis, we hypothesised that OPN could drive oval cells (OC) expansion and DR and signal to hepatic stellate cells (HSC) to promote scarring.
共有 16360 条符合本次的查询结果, 用时 5.2537959 秒